Investment
Features
FeesSafety
Academy
More
Pluang+

Our Bond converts $3.3M debt to equity at 200% premium, easing 2026 debt and boosting growth funds.

Company Fundamentals
16 Jun 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

Our Bond, Inc. announced that a major investor exchanged $3.3 million of outstanding debt for convertible preferred equity at a conversion price more than 200% above recent market levels. This transaction reduces the company's 2026 debt burden by $4.3 million and strengthens its balance sheet, reflecting strong investor confidence in Bond's long-term growth. Additionally, another investor agreed to delay nearly $1 million of debt payments from 2026 to 2027, allowing Bond to invest more in growth initiatives. The company aims to expand its AI-powered Preventative Personal Security platform, which operates in 28 countries and has supported over 1.4 million security requests.

More News

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays increased its price target for Hudbay Minerals to $32 from $30, citing strong growth prospects in copper mining. Despite a recent nearly 30% stock pullback due to market sentiment, Hudbay maintains a solid financial position with near-zero n...

Analyst Insights
Bullish
40 minutes ago
Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley reported strong Q2 2026 results, with earnings per share of $3.46 surpassing estimates of $2.89 and revenue of $21.35 billion beating forecasts of $19.67 billion. This marks significant year-over-year growth from $16.79 billion, driven...

Company Fundamentals
Bullish
43 minutes ago
Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...

Market News
Bullish
43 minutes ago
Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...

Others
Neutral
43 minutes ago
Travelers are more strategic with rewards programs, seeking value and ease amid rising loyalty challenges.

Travelers are more strategic with rewards programs, seeking value and ease amid rising loyalty challenges.

New research from iSeatz reveals that U.S. travelers are increasingly strategic about travel rewards programs, with 40% treating them as financial optimization tools and 60% belonging to multiple programs. Despite high enrollment, many travelers find...

Others
Neutral
43 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App